Management of a Parkinson’s disease patient with severe COVID-19 pneumonia
Elderly populations with underlying chronic diseases are more vulnerable to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and have higher mortality. Parkinson’s disease (PD) is a neurodegenerative disease that occurs more often in elderly people. Currently, little is known a...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2020-08-01
|
| Series: | Therapeutic Advances in Chronic Disease |
| Online Access: | https://doi.org/10.1177/2040622320949423 |
| _version_ | 1818456607516786688 |
|---|---|
| author | Jingwen Li Xi Long Chunli Zhu Ruiying Wang Shaoping Hu Tao Wang Jinghong Li Zhicheng Lin Nian Xiong |
| author_facet | Jingwen Li Xi Long Chunli Zhu Ruiying Wang Shaoping Hu Tao Wang Jinghong Li Zhicheng Lin Nian Xiong |
| author_sort | Jingwen Li |
| collection | DOAJ |
| description | Elderly populations with underlying chronic diseases are more vulnerable to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and have higher mortality. Parkinson’s disease (PD) is a neurodegenerative disease that occurs more often in elderly people. Currently, little is known about whether patients with PD are more susceptible to novel coronavirus disease 2019 (COVID-19) and whether the treatment of PD would affect the management of COVID-19 or vice versa. Here, we report a case of a PD patient with severe COVID-19 pneumonia in Wuhan, China. After diagnosis of COVID-19, this PD patient had worsening of motor symptoms, complicated with acute hypoxemic respiratory failure, urinary tract infection, and acute encephalopathy. In addition to treatment for COVID-19 and urinary tract infection, we adjusted anti-PD medicine by stepwise increasing of dose, resulting in better control of her mobility symptoms and non-motor symptoms. |
| first_indexed | 2024-12-14T22:29:22Z |
| format | Article |
| id | doaj.art-5bb9880bba1a42e1ab883d1bee129107 |
| institution | Directory Open Access Journal |
| issn | 2040-6231 |
| language | English |
| last_indexed | 2024-12-14T22:29:22Z |
| publishDate | 2020-08-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Therapeutic Advances in Chronic Disease |
| spelling | doaj.art-5bb9880bba1a42e1ab883d1bee1291072022-12-21T22:45:17ZengSAGE PublishingTherapeutic Advances in Chronic Disease2040-62312020-08-011110.1177/2040622320949423Management of a Parkinson’s disease patient with severe COVID-19 pneumoniaJingwen LiXi LongChunli ZhuRuiying WangShaoping HuTao WangJinghong LiZhicheng LinNian XiongElderly populations with underlying chronic diseases are more vulnerable to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and have higher mortality. Parkinson’s disease (PD) is a neurodegenerative disease that occurs more often in elderly people. Currently, little is known about whether patients with PD are more susceptible to novel coronavirus disease 2019 (COVID-19) and whether the treatment of PD would affect the management of COVID-19 or vice versa. Here, we report a case of a PD patient with severe COVID-19 pneumonia in Wuhan, China. After diagnosis of COVID-19, this PD patient had worsening of motor symptoms, complicated with acute hypoxemic respiratory failure, urinary tract infection, and acute encephalopathy. In addition to treatment for COVID-19 and urinary tract infection, we adjusted anti-PD medicine by stepwise increasing of dose, resulting in better control of her mobility symptoms and non-motor symptoms.https://doi.org/10.1177/2040622320949423 |
| spellingShingle | Jingwen Li Xi Long Chunli Zhu Ruiying Wang Shaoping Hu Tao Wang Jinghong Li Zhicheng Lin Nian Xiong Management of a Parkinson’s disease patient with severe COVID-19 pneumonia Therapeutic Advances in Chronic Disease |
| title | Management of a Parkinson’s disease patient with severe COVID-19 pneumonia |
| title_full | Management of a Parkinson’s disease patient with severe COVID-19 pneumonia |
| title_fullStr | Management of a Parkinson’s disease patient with severe COVID-19 pneumonia |
| title_full_unstemmed | Management of a Parkinson’s disease patient with severe COVID-19 pneumonia |
| title_short | Management of a Parkinson’s disease patient with severe COVID-19 pneumonia |
| title_sort | management of a parkinson s disease patient with severe covid 19 pneumonia |
| url | https://doi.org/10.1177/2040622320949423 |
| work_keys_str_mv | AT jingwenli managementofaparkinsonsdiseasepatientwithseverecovid19pneumonia AT xilong managementofaparkinsonsdiseasepatientwithseverecovid19pneumonia AT chunlizhu managementofaparkinsonsdiseasepatientwithseverecovid19pneumonia AT ruiyingwang managementofaparkinsonsdiseasepatientwithseverecovid19pneumonia AT shaopinghu managementofaparkinsonsdiseasepatientwithseverecovid19pneumonia AT taowang managementofaparkinsonsdiseasepatientwithseverecovid19pneumonia AT jinghongli managementofaparkinsonsdiseasepatientwithseverecovid19pneumonia AT zhichenglin managementofaparkinsonsdiseasepatientwithseverecovid19pneumonia AT nianxiong managementofaparkinsonsdiseasepatientwithseverecovid19pneumonia |